\
&
Contact us
\
&
Contact us
Partnership website: https://eosc-portal.eu/
European Partnership status fortifies EOSC with European funding of almost €500 million and an in-kind contribution of the partners of also €500 million. The aim is to improve the storing, sharing and especially the combining and reusing of research data across borders and scientific disciplines.
The Partnership brings together institutional, national and European initiatives and engages all relevant stakeholders to co-design and deploy a European Research Data Commons where data are Findable, Accessible, Interoperable and Reusable (FAIR).
This European contribution to a ‘Web of FAIR Data and Related Services for Science’ will enhance the possibilities for researchers to find, share and reuse publications, data, and software, leading to new insights and innovations, higher research productivity and improved reproducibility in science.
The Partnership represents a new governance for EOSC as the first implementation phase of EOSC begins. The Partnership includes the European Commission, the EOSC Steering Board and the EOSC Association. These three entities together comprise the Tripartite Collaboration, which serves to govern EOSC.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
